August 25, 2026 12:39 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Reservation for poor, not caste’: Stir at Delhi’s Jantar Mantar | Dalit woman 'gangrape-murder' shocker in Karnataka: 4 arrested after body found in well | India dismisses Pakistan's 'frustration' over US envoy's J&K remark | Centre denies US visit clearance to Telangana CM Revanth Reddy, says programmes 'not appropriate' | Delhi Police register FIR in pellet gun case after Rahul Gandhi's sit-in | Rahul Gandhi stages dharna at Delhi police station over CJP protest crackdown, targets Amit Shah | CJP school tour turns chaotic in Jaipur: Cars vandalised, stones pelted as Ashutosh Ranka alleges BJP ‘goons’ attack | Vande Mataram row: Kangana Ranaut slams Sharmila Tagore, says ‘come out of Hindu-Muslim mindset’ | Jadavpur erupts again: ABVP-SFI clash, police barricades shattered as fresh tension grips area | Ex-Congress MP and 1984 anti-Sikh riots convict Sajjan Kumar dies while serving life sentence
Adar Poonawalla
Adar Poonawalla Twitter page

Will take 4-5 years until everyone gets COVID-19 vaccine, says Serum Institute of India CEO Adar Poonawalla 

| @indiablooms | Sep 14, 2020, at 11:40 pm

Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.

He told the Financial Times that pharmaceutical companies were not increasing production capacity quickly enough to vaccinate the global population in less time.

“It’s going to take four to five years until everyone gets the vaccine on this planet,” said Poonawalla, who estimated that if the Covid-19 shot is a two-dose vaccine — such as measles or rotavirus — the world will need 15bn doses.  

Based in the western Indian city of Pune, the family-run Serum Institute has partnered with five international pharmaceutical firms, including AstraZeneca and Novavax, to develop a Covid-19 vaccine and committed to produce 1bn doses, of which it has pledged half to India. The company may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik vaccine, reports the newspaper.

India is one of the nations in the world that has registered a high number of COVID-19 cases for the past several months.

The virus is believed to have originated from China.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.